Literature DB >> 1422615

Factors associated with relapse among opiate addicts in an out-patient detoxification programme.

S Unnithan1, M Gossop, J Strang.   

Abstract

Relapse is a central problem in the treatment of addictive behaviour, and a specific problem in the out-patient treatment of the opiate withdrawal syndrome. This study investigated factors associated with relapse among 42 opiate addicts receiving out-patient detoxification treatment at a London drug-dependence clinic. All subjects completed a questionnaire about their social, psychological, and environmental circumstances in the week before interview, and were interviewed within the first two weeks of the programme. Forty per cent had lapsed to illicit heroin abuse within the previous week. Interpersonal factors and drug-related cues were associated with lapse to opiate use. Most subjects encountered a range of high-risk situations, such as regularly meeting other drug users and being offered drugs, and persistent negative mood states.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422615     DOI: 10.1192/bjp.161.5.654

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  12 in total

1.  Use of methadone.

Authors:  I B Anderson; T E Kearney
Journal:  West J Med       Date:  2000-01

Review 2.  The pharmacological treatment of opioid addiction--a clinical perspective.

Authors:  Philipp Lobmaier; Michael Gossop; Helge Waal; Jorgen Bramness
Journal:  Eur J Clin Pharmacol       Date:  2010-02-19       Impact factor: 2.953

3.  Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?

Authors:  Maria A Sullivan; Adam Bisaga; John J Mariani; Andrew Glass; Frances R Levin; Sandra D Comer; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2013-07-01       Impact factor: 4.492

4.  Early outcomes following low dose naltrexone enhancement of opioid detoxification.

Authors:  Paolo Mannelli; Ashwin A Patkar; Kathleen Peindl; Edward Gottheil; Li-Tzy Wu; David A Gorelick
Journal:  Am J Addict       Date:  2009 Mar-Apr

5.  Conditioned effects of heroin on proinflammatory mediators require the basolateral amygdala.

Authors:  Jennifer L Szczytkowski; Donald T Lysle
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

6.  Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcer.

Authors:  Jeremiah W Bertz; Emily L Jackson; Davina R Barron; James H Woods
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

7.  Insights into the Neurobiology of Craving in Opioid Use Disorder.

Authors:  Lindsay M Lueptow; Elizabeth C Shashkova; Margaret G Miller; Christopher J Evans; Catherine M Cahill
Journal:  Curr Anesthesiol Rep       Date:  2020-09-29

8.  Six-month follow-up study of ultrarapid opiate detoxification with naltrexone.

Authors:  Mohammad Forozeshfard; Babak Hosseinzadeh Zoroufchi; Mohammad Bagher Saberi Zafarghandi; Razieh Bandari; Behzad Foroutan
Journal:  Int J High Risk Behav Addict       Date:  2014-09-17

9.  A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study.

Authors:  Anne Bukten; Jo Røislien; Svetlana Skurtveit; Helge Waal; Michael Gossop; Thomas Clausen
Journal:  BMC Psychiatry       Date:  2013-10-16       Impact factor: 3.630

10.  Relationship of reasons and fears of treatment with outcome in substance using population attending a de-addiction centre.

Authors:  Siddharth Sarkar; Naresh Nebhinani; Jasveen Kaur; Kamalpreet Kaur; Sandhya Ghai; Debasish Basu
Journal:  Ind Psychiatry J       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.